As Sen. Cory Booker (D-N.J.) eyes the 2020 White House race, he's scrambling to mitigate any damage that may have been done by his decision to accept campaign donations from pharmaceutical companies. As public outrage boils over about high drug prices, most presidential contenders, such as Sen. Amy Klobuchar (D-Minn.), are trying to get in front of the issue by offering plans they believe will demonstrate a hard stance against Big Pharma.
from Kaiser Health News http://bit.ly/2SDdo0z
February 12, 2019
Rose
Health News, Kaiser Health News
No comments
Related Posts:
First Edition: April 20, 2018Today's early morning highlights from the major news organizations. from Kaiser Health News https://ift.tt/2Hh1X5F … Read More
Growth Of Prescription Drugs Spending Slowing, But That Won’t Necessarily Be Reflected For Consumers“We’re not suggesting that nobody is seeing higher costs," said Murray Aitken, of the IQVIA Institute for Human Data Science, which released the numbers. "We’re just saying that when we roll everything up, the amount received… Read More
Podcast: KHN’s ‘What The Health?’ Nothing In Health Care Ever Goes Away… Read More
FDA Panel’s Approval Of Epilepsy Drug Paves Way For U.S.’s First Cannabis-Derived Prescription MedicineAn FDA advisory panel gave the green light to the drug, which treats epilepsy, and the full agency is expected to give its approval, as well, sometime in June. from Kaiser Health News https://ift.tt/2J9Le4G … Read More
Calif. Leads Nation In Pushing Back Against Trump Administration Health Policies… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment